Mark R. Gilbert
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Co-authors
- Terri S. Armstrong (141 shared papers)Minesh P. Mehta (73 shared papers)Kenneth Aldape (60 shared papers)Roger Stupp (11 shared papers)Patrick Y. Wen (40 shared papers)Wolfgang Wick (11 shared papers)David A. Reardon (17 shared papers)Kathleen R. Lamborn (20 shared papers)
- Journals
- Neuro-Oncology (102 papers)Journal of Clinical Oncology (69 papers)Journal of Neuro-Oncology (46 papers)Current Oncology Reports (13 papers)Neuro-Oncology Advances (13 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark R. Gilbert
482 papers receiving 25.7k citations
Mark R. Gilbert's Hit Papers
Peers
Comparison fields: 5 of 162
- Genetics 13.9k
- Cancer Research 3.8k
- Oncology 4.7k
- Pulmonary and Respiratory Medicine 4.9k
- Neurology 2.1k
Countries citing papers authored by Mark R. Gilbert
This map shows the geographic impact of Mark R. Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Gilbert more than expected).
Fields of papers citing papers by Mark R. Gilbert
This network shows the impact of papers produced by Mark R. Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Gilbert. The network helps show where Mark R. Gilbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Gilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 504 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Hit paper breakdown → | 2010 | 2877 |
| 2 | Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial Hit paper breakdown → | 2013 | 788 |
| 3 | Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity Hit paper breakdown → | 2008 | 691 |
| 4 | Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma Hit paper breakdown → | 2010 | 642 |
| 5 | Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System Hit paper breakdown → | 2010 | 564 |
| 6 | Immunotherapy response assessment in neuro-oncology: a report of the RANO working group Hit paper breakdown → | 2015 | 510 |
| 7 | IDH mutation in glioma: molecular mechanisms and potential therapeutic targets Hit paper breakdown → | 2020 | 452 |
| 8 | 2005 | 432 | |
| 9 | 2007 | 428 | |
| 10 | 1991 | 382 | |
| 11 | 2013 | 358 | |
| 12 | Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology Hit paper breakdown → | 2013 | 356 |
| 13 | Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy Hit paper breakdown → | 2018 | 354 |
| 14 | 2009 | 337 | |
| 15 | 2008 | 336 | |
| 16 | 2009 | 308 | |
| 17 | 2010 | 293 | |
| 18 | 2015 | 271 | |
| 19 | 2012 | 245 | |
| 20 | 2009 | 235 |
About Mark R. Gilbert
Mark R. Gilbert is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 504 papers that have together received 26.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (288 papers), Brain Metastases and Treatment (76 papers), Cancer, Hypoxia, and Metabolism (32 papers), Cancer Treatment and Pharmacology (30 papers), Neuroblastoma Research and Treatments (25 papers), Cancer Immunotherapy and Biomarkers (25 papers), Cancer Genomics and Diagnostics (23 papers) and Radiomics and Machine Learning in Medical Imaging (23 papers). The work is most often cited by research in Genetics (13.9k citations), Cancer Research (3.8k citations), Oncology (4.7k citations), Pulmonary and Respiratory Medicine (4.9k citations) and Neurology (2.1k citations). Mark R. Gilbert has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Terri S. Armstrong, Minesh P. Mehta, Kenneth Aldape, Roger Stupp, Patrick Y. Wen, Wolfgang Wick, David A. Reardon, Kathleen R. Lamborn, Timothy F. Cloughesy and Monika E. Hegi. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Current Oncology Reports and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.